Please use this identifier to cite or link to this item:
Title: Metabolic control of YAP/TAZ by the Mevalonate Pathway
Authors: Sorrentino, Giovanni
Keywords: CancerSmall moleculesHippo pathwayMetabolismp53
Issue Date: 28-Apr-2014
Publisher: Università degli studi di Trieste
Abstract: The YAP and TAZ mediators of the Hippo pathway (hereafter called YAP/TAZ) promote tissue proliferation and organ growth. However, how their biological properties intersect with cellular metabolism remains unexplained. Here, we show that YAP/TAZ activity is controlled by the SREBP/mevalonate pathway. Inhibition of the rate-limiting enzyme of this pathway (HMG-CoA reductase) by statins opposes YAP/TAZ nuclear localization and transcriptional responses. Mechanistically, the geranylgeranyl pyrophosphate produced by the mevalonate cascade is required for activation of Rho GTPases that, in turn, activate YAP/TAZ by inhibiting their phosphorylation and promoting their nuclear accumulation. The mevalonate–YAP/TAZ axis is required for proliferation and self-renewal of breast cancer cells. In Drosophila melanogaster, inhibition of mevalonate biosynthesis and geranylgeranylation blunts the eye overgrowth induced by Yorkie, the YAP/TAZ orthologue. In tumour cells, YAP/TAZ activation is promoted by increased levels of mevalonic acid produced by SREBP transcriptional activity, which is induced by its oncogenic cofactor mutant p53. These findings reveal an additional layer of YAP/TAZ regulation by metabolic cues.
Description: 2012/2013
NBN: urn:nbn:it:units-12541
Appears in Collections:Scienze biologiche

Files in This Item:
File Description SizeFormat 
Tesi Sorrentino.pdfThesis8.11 MBAdobe PDFView/Open
Show full item record

CORE Recommender

Page view(s)

checked on Mar 17, 2018


checked on Mar 17, 2018

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.